Diagnosis and Management of Malignant Pleural Effusion: A Decade in Review

• Published in: Diagnostics (Basel) Vol. 12; no. 4; p. 1016
• Main Authors: Jacobs, Blake, Sheikh, Ghias, Youness, Houssein A, Keddissi, Jean I, Abdo, Tony
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 18.04.2022; MDPI
• Subjects: Airway management; Biopsy; Cancer; Cellular biology; chest tube; Clinical trials; Dyspnea; Hospitalization; indwelling pleural catheter; Length of stay; malignant pleural effusion; Medical prognosis; Mesothelioma; Ostomy; Patients; Pleural effusion; pleurodesis; Radiation therapy; Review; talc; Thoracentesis; thoracoscopy; Ultrasonic imaging; chest tube; malignant pleural effusion; talc; thoracoscopy; indwelling pleural catheter; pleurodesis
• ISSN: 2075-4418; 2075-4418
• DOI: 10.3390/diagnostics12041016

Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality. Treatment is mainly palliative, with symptomatic management achieved via effusion drainage and pleurodesis. Pleurodesis may be hastened by administering a sclerosing agent through a thoracostomy tube, thoracoscopy, or an indwelling pleural catheter (IPC). Over the last decade, several randomized controlled studies shaped the current management of MPE in favor of an outpatient-based approach with a notable increase in IPC usage. Patient preferences remain essential in choosing optimal therapy, especially when the lung is expandable. In this article, we reviewed the last 10 to 15 years of MPE literature with a particular focus on the diagnosis and evolving management.